Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo
- PMID: 1985787
Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo
Abstract
The interaction between hyperthermia and cis-diamminedichloroplatinum(II) (c-DDP) given in various schedules as an adjuvant to radiation treatment was investigated in a C3H mouse mammary carcinoma in vivo. Both hyperthermia (43.5 degrees C for 60 min) and c-DDP (6 mg/kg i.p.) caused a delay in tumor growth when given individually. When c-DDP was given 4 h prior to hyperthermia, the increase in tumor growth time corresponded to an additive effect, but when the interval was reduced to 15 min, the tumor growth delay was significantly greater than additive. The modifying effect of these schedules on radiation was studied using local tumor control (50% tumor control dose) as the endpoint. c-DDP alone did not result in any enhancement of tumor control, irrespective of whether it was given 15 min or 4 h after irradiation. In contrast, heat treatment at 43.5 degrees C for 60 min given 4 h after irradiation resulted in a significant reduction in the 50% tumor control dose, with an enhancement ratio of 1.8. From a clamped local tumor control assay, it was found that c-DDP selectively killed aerobic cells, whereas hyperthermia was primarily directed toward the hypoxic clonogenic cells in the tumors. Combining the two modalities (simultaneously) resulted in a significant additional increase in the killing of well-oxygenated clonogenic cells, but the destruction of hypoxic cells was not different from that obtained after heat alone.
Similar articles
-
Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.Cancer Res. 1990 Jul 1;50(13):3826-31. Cancer Res. 1990. PMID: 2354434
-
Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.Int J Hyperthermia. 2004 Jun;20(4):393-404. doi: 10.1080/02656730310001619370. Int J Hyperthermia. 2004. PMID: 15204520
-
Combined modality therapy with bleomycin, hyperthermia, and radiation.Cancer Res. 1988 Nov 15;48(22):6291-7. Cancer Res. 1988. PMID: 2460220
-
Fractionated thermochemotherapy in vivo of a C3H mouse mammary carcinoma.Radiother Oncol. 1991 Jul;21(3):171-8. doi: 10.1016/0167-8140(91)90034-e. Radiother Oncol. 1991. PMID: 1924852 Review.
-
Hyperthermic effects on animal tissues.Radiology. 1977 May;123(2):483-7. doi: 10.1148/123.2.483. Radiology. 1977. PMID: 322206 Review.
Cited by
-
Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line.Cancer Chemother Pharmacol. 1993;32(6):419-24. doi: 10.1007/BF00685884. Cancer Chemother Pharmacol. 1993. PMID: 7903066
-
Hyperthermic enhancement of cytotoxicity and increased uptake of cis-diamminedichloroplatinum(II) in cultured human esophageal cancer cells.Jpn J Cancer Res. 1993 Mar;84(3):336-40. doi: 10.1111/j.1349-7006.1993.tb02875.x. Jpn J Cancer Res. 1993. PMID: 8486532 Free PMC article.
-
Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells.Cancer Chemother Pharmacol. 1994;34(4):302-6. doi: 10.1007/BF00686037. Cancer Chemother Pharmacol. 1994. PMID: 8033297
-
Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment.Cancers (Basel). 2022 Jan 26;14(3):625. doi: 10.3390/cancers14030625. Cancers (Basel). 2022. PMID: 35158893 Free PMC article. Review.
-
Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.Cancer Chemother Pharmacol. 1992;30(4):277-80. doi: 10.1007/BF00686295. Cancer Chemother Pharmacol. 1992. PMID: 1643695